185 related articles for article (PubMed ID: 14562031)
21. Targeting the A3 adenosine receptor for glaucoma treatment (review).
Fishman P; Cohen S; Bar-Yehuda S
Mol Med Rep; 2013 Jun; 7(6):1723-5. PubMed ID: 23563604
[TBL] [Abstract][Full Text] [Related]
22. Adenosine acts as a chemoprotective agent by stimulating G-CSF production: a role for A1 and A3 adenosine receptors.
Fishman P; Bar-Yehuda S; Farbstein T; Barer F; Ohana G
J Cell Physiol; 2000 Jun; 183(3):393-8. PubMed ID: 10797314
[TBL] [Abstract][Full Text] [Related]
23. Exploring the Role of N
Petrelli R; Scortichini M; Kachler S; Boccella S; Cerchia C; Torquati I; Del Bello F; Salvemini D; Novellino E; Luongo L; Maione S; Jacobson KA; Lavecchia A; Klotz KN; Cappellacci L
J Med Chem; 2017 May; 60(10):4327-4341. PubMed ID: 28447789
[TBL] [Abstract][Full Text] [Related]
24. Adenosine Receptors as Novel Targets for the Treatment of Various Cancers.
Gorain B; Choudhury H; Yee GS; Bhattamisra SK
Curr Pharm Des; 2019; 25(26):2828-2841. PubMed ID: 31333092
[TBL] [Abstract][Full Text] [Related]
25. Suppression of macrophage inflammatory protein (MIP)-1alpha production and collagen-induced arthritis by adenosine receptor agonists.
Szabó C; Scott GS; Virág L; Egnaczyk G; Salzman AL; Shanley TP; Haskó G
Br J Pharmacol; 1998 Sep; 125(2):379-87. PubMed ID: 9786512
[TBL] [Abstract][Full Text] [Related]
26. Anticancer activity study of A
Marucci G; Santinelli C; Buccioni M; Navia AM; Lambertucci C; Zhurina A; Yli-Harja O; Volpini R; Kandhavelu M
Life Sci; 2018 Jul; 205():155-163. PubMed ID: 29763615
[TBL] [Abstract][Full Text] [Related]
27. The A3 adenosine receptor (A3AR): therapeutic target and predictive biological marker in rheumatoid arthritis.
Fishman P; Cohen S
Clin Rheumatol; 2016 Sep; 35(9):2359-62. PubMed ID: 26886128
[TBL] [Abstract][Full Text] [Related]
28. Treatment of Plaque-Type Psoriasis With Oral CF101: Data from a Phase II/III Multicenter, Randomized, Controlled Trial.
David M; Gospodinov DK; Gheorghe N; Mateev GS; Rusinova MV; Hristakieva E; Solovastru LG; Patel RV; Giurcaneanu C; Hitova MC; Purcaru AI; Horia B; Tsingov II; Yankova RK; Kadurina MI; Ramon M; Rotaru M; Simionescu O; Benea V; Demerdjieva ZV; Cosgarea MR; Morariu HS; Michael Z; Cristodor P; Nica C; Silverman MH; Bristol DR; Harpaz Z; Farbstein M; Cohen S; Fishman P
J Drugs Dermatol; 2016 Aug; 15(8):931-8. PubMed ID: 27537992
[TBL] [Abstract][Full Text] [Related]
29. Disruption of the A(3) adenosine receptor gene in mice and its effect on stimulated inflammatory cells.
Salvatore CA; Tilley SL; Latour AM; Fletcher DS; Koller BH; Jacobson MA
J Biol Chem; 2000 Feb; 275(6):4429-34. PubMed ID: 10660615
[TBL] [Abstract][Full Text] [Related]
30. Molecular basis for subtype-specific desensitization of inhibitory adenosine receptors. Analysis of a chimeric A1-A3 adenosine receptor.
Palmer TM; Benovic JL; Stiles GL
J Biol Chem; 1996 Jun; 271(25):15272-8. PubMed ID: 8663009
[TBL] [Abstract][Full Text] [Related]
31. Short- and long-term A3 adenosine receptor activation inhibits the Na+/H+ exchanger NHE3 activity and expression in opossum kidney cells.
Di Sole F; Cerull R; Babich V; Casavola V; Helmle-Roth C; Burckhardt G
J Cell Physiol; 2008 Jul; 216(1):221-33. PubMed ID: 18286509
[TBL] [Abstract][Full Text] [Related]
32. The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5'-N-methyluronamide, is protective in two murine models of colitis.
Mabley J; Soriano F; Pacher P; Haskó G; Marton A; Wallace R; Salzman A; Szabó C
Eur J Pharmacol; 2003 Apr; 466(3):323-9. PubMed ID: 12694816
[TBL] [Abstract][Full Text] [Related]
33. A3 adenosine receptor activation in melanoma cells: association between receptor fate and tumor growth inhibition.
Madi L; Bar-Yehuda S; Barer F; Ardon E; Ochaion A; Fishman P
J Biol Chem; 2003 Oct; 278(43):42121-30. PubMed ID: 12865431
[TBL] [Abstract][Full Text] [Related]
34. PARG regulates the proliferation and differentiation of DCs and T cells via PARP/NF‑κB in tumour metastases of colon carcinoma.
Wang JQ; Tang Y; Li QS; Xiao M; Li M; Sheng YT; Yang Y; Wang YL
Oncol Rep; 2019 May; 41(5):2657-2666. PubMed ID: 30864743
[TBL] [Abstract][Full Text] [Related]
35. Knockout of A3 adenosine receptors reduces mouse intraocular pressure.
Avila MY; Stone RA; Civan MM
Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):3021-6. PubMed ID: 12202525
[TBL] [Abstract][Full Text] [Related]
36. Effects of stable adenosine receptor agonists on bone marrow hematopoietic cells as inferred from the cytotoxic action of 5-fluorouracil.
Pospísil M; Hofer M; Vacek A; Znojil V; Pipalová I
Physiol Res; 2004; 53(5):549-56. PubMed ID: 15479134
[TBL] [Abstract][Full Text] [Related]
37. Endogenous adenosine A3 receptor activation selectively alleviates persistent pain states.
Little JW; Ford A; Symons-Liguori AM; Chen Z; Janes K; Doyle T; Xie J; Luongo L; Tosh DK; Maione S; Bannister K; Dickenson AH; Vanderah TW; Porreca F; Jacobson KA; Salvemini D
Brain; 2015 Jan; 138(Pt 1):28-35. PubMed ID: 25414036
[TBL] [Abstract][Full Text] [Related]
38. Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion.
Huang S; Apasov S; Koshiba M; Sitkovsky M
Blood; 1997 Aug; 90(4):1600-10. PubMed ID: 9269779
[TBL] [Abstract][Full Text] [Related]
39. Adenosine is upregulated during peritonitis and is involved in downregulation of inflammation.
Rogachev B; Ziv NY; Mazar J; Nakav S; Chaimovitz C; Zlotnik M; Douvdevani A
Kidney Int; 2006 Aug; 70(4):675-81. PubMed ID: 16788688
[TBL] [Abstract][Full Text] [Related]
40. IB-MECA, an A3 adenosine receptor agonist prevents bone resorption in rats with adjuvant induced arthritis.
Rath-Wolfson L; Bar-Yehuda S; Madi L; Ochaion A; Cohen S; Zabutti A; Fishman P
Clin Exp Rheumatol; 2006; 24(4):400-6. PubMed ID: 16956430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
